Good results after fluoroscopic-guided intra-articular injections in the treatment of adhesive capsulitis of the shoulder.
The purpose of the present study was the prospective evaluation of the results of fluoroscopic-guided intra-articular cortisone injection series in the treatment of adhesive capsulitis of the shoulder. Twenty-five patients (9 m, 16 w) with a mean age of 49 ± 8 years and stage II frozen shoulder syndrome according to the Reeves classification were treated with an intra-articular cortisone injection series (3 injections at 0, 4, 12, weeks). Clinical examination, ASES score and SF 36 score were performed at 0, 4, 8, 12 weeks, 6 and 12 months. In the results, significant improvements were seen in flexion (99 ± 30°-119 ± 31°, P < .0001), abduction (72 ± 24-99 ± 34°, P < .0001), external rotation (14 ± 16°-28 ± 21°, P < .0001) and internal rotation already at first follow-up after 4 weeks of treatment. The results were confirmed at any other follow-up. ASES score improved from 28 ± 13 to 45 ± 18 after 4 weeks (P < .0001), 59 ± 21 after 8 weeks (P < .0001), 63 ± 25 at 3 months (P < .0001), 64 ± 28 (P < .0001) at 6 months and 73 ± 27 (P < .0001) points at final follow-up after 1 year. Evaluation of the SF-36 Score showed significant improvements in almost all categories (physical and mental) after 4 weeks of treatment (P < .05). In conclusion, a fluoroscopic-guided intra-articular injection series of cortisone is an effective treatment option in frozen shoulder syndrome leading to a fast pain reduction and increased range motion.
Lorbach
Olaf
O
Department of Orthopedic and Trauma Surgery, Klinikum Osnabrück, Am Finkenhügel 1, 49076 Osnabrück, Germany. olaf.lorbach@gmx.de
Kieb
Matthias
M
Scherf
Cornelia
C
Seil
Romain
R
Kohn
Dieter
D
Pape
Dietrich
D
D000328:Adult; D000779:Anesthetics, Local / Q000008:administration & dosage*; D002045:Bupivacaine / Q000008:administration & dosage; D002062:Bursitis / Q000175:diagnosis / Q000188:drug therapy*; D015331:Cohort Studies; D003348:Cortisone / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005471:Fluoroscopy; D005500:Follow-Up Studies; D006801:Humans; D007270:Injections, Intra-Articular; D008297:Male; D008619:Mepivacaine / Q000008:administration & dosage; D008875:Middle Aged; D010147:Pain Measurement / Q000187:drug effects; D017060:Patient Satisfaction; D016059:Range of Motion, Articular / Q000187:drug effects* / Q000502:physiology; D012189:Retrospective Studies; D012720:Severity of Illness Index; D012785:Shoulder Joint; D020069:Shoulder Pain / Q000175:diagnosis / Q000188:drug therapy; D016896:Treatment Outcome
D000779:Anesthetics, Local; D008619:Mepivacaine; D003348:Cortisone; D002045:Bupivacaine